Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Amazon (NASDAQ: AMZN) stock has been hit especially hard in the latest market sell-off. Vertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure Bruker’s LUMOS II FT-IR microscope ...

As of 9:58:40 AM EDT. Market Open.

This publication is Open Access under the license indicated. Learn More ...